3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
3
beta-Thalassemia
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Thalassemia
1
Shwachman-Diamond Syndrome
1
Primary Myelofibrosis
1
Neurofibromatosis 1
1
Neoplasm, Residual
1
Multiple Myeloma
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
Influenza, Human
1
Hemoglobinuria, Paroxysmal
1
Congenital amegakaryocytic thrombocytopenia
1
Chromosome Aberrations
1
Chromosome 7, monosomy
1
Bone Marrow Failure Disorders
1
Anemia, Sickle Cell
1
Anemia, Refractory, with Excess of Blasts
1
Anemia, Hypochromic
1
Anemia, Diamond-Blackfan
1
Interventions
Vincristine
9
Cyclophosphamide
8
Magnetic Resonance Spectroscopy
7
X-Rays
6
Temozolomide
6
Specimen Handling
6
Phantoms, Imaging
6
Irinotecan
6
Biopsy
5
Radiotherapy
4
Radiation
4
Nuclear Medicine Department, Hospital
4
Dactinomycin
4
fludarabine
3
Vinorelbine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
Proton Therapy
2
LY3023414
2
Ifosfamide
2
Filgrastim
2
Etoposide
2
Doxorubicin
2
Dexrazoxane
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
thymoglobulin
×
90 days
×
Clear all
No trials found.